EMA Panel Recommends Approval for Merck's Injectable Keytruda

A key committee of the European Medicines Agency has recommended approval for an injectable version of Merck's cancer drug Keytruda, paving the way for potential authorization across the European Union. This subcutaneous formulation aims to offer a more convenient alternative to intravenous administration for patients with various cancers. The recommendation, issued on September 19, 2025, follows positive clinical data and could enhance treatment accessibility in Europe.

End of patent protection for weight loss injections benefits patients

Patent protection for semaglutide in weight loss injections like Ozempic and Wegovy is expiring in Europe. This paves the way for cheaper generics to enter the market and could lower high prices. Patients with obesity stand to benefit from improved access.

Pfizer stock rises after aligning with Trump on drug pricing

October 01, 2025 由 AI 报道

Pfizer's shares climbed on Monday after the company expressed support for former President Donald Trump's proposal to allow imports of lower-priced drugs from Canada. This stance marks a shift for the pharmaceutical giant, which has historically opposed such measures. The move comes amid ongoing debates over U.S. drug costs.

Lawsuits claim Tylenol use in pregnancy causes autism

October 02, 2025 由 AI 报道

More than 100 lawsuits have been filed against acetaminophen manufacturers, including Johnson & Johnson, alleging that the drug's use during pregnancy increases the risk of autism and ADHD in children. These legal actions stem from scientific studies showing associations between prenatal exposure and neurodevelopmental disorders. The cases highlight growing concerns over the safety of a widely used pain reliever.